LifeStance Health Group, Inc. Form 8-K Summary
Business Context and Reporting Period
LifeStance Health Group, Inc. filed a Form 8-K dated June 1, 2022, reporting the results of its annual meeting of stockholders held that day. The company is a Delaware corporation whose common stock trades on Nasdaq under the symbol LFST.
Financial and Operating Metrics
This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating performance metrics.
Material Changes and Meeting Results
Stockholders elected all three Class I director nominees to three-year terms:
| Nominee | For | Withhold | Broker Non-Votes |
|---|---|---|---|
| Jeffrey Crisan | 275,712,192 | 35,528,451 | 1,670,285 |
| Katherine Wood | 275,789,101 | 35,451,542 | 1,670,285 |
| Seema Verma | 278,655,499 | 32,585,143 | 1,679,285 |
Stockholders also ratified PricewaterhouseCoopers LLP as the company’s independent registered public accounting firm for the year ending December 31, 2022.
| Proposal 2 Vote | Votes |
|---|---|
| For | 312,861,031 |
| Against | 49,684 |
| Abstain | 213 |
Guidance, Outlook, Risks, and Unusual Items
The filing contains no financial guidance, outlook, management commentary, risk updates, contingencies, or unusual financial items. It identifies the company as an emerging growth company.
Key Facts for Investors to Verify
- Confirm the newly elected directors’ three-year Class I terms and any subsequent changes to board composition.
- Verify PwC’s appointment and review subsequent filings for audit-related matters.
- Consult the company’s periodic reports for financial results, liquidity, debt, operating trends, and guidance, which are not included in this filing.